These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69. Resolution of Inflammation after Skeletal Muscle Ischemia-Reperfusion Injury: A Focus on the Lipid Mediators Lipoxins, Resolvins, Protectins and Maresins. Barnig C; Lutzweiler G; Giannini M; Lejay A; Charles AL; Meyer A; Geny B Antioxidants (Basel); 2022 Jun; 11(6):. PubMed ID: 35740110 [TBL] [Abstract][Full Text] [Related]
70. Towards targeting resolution pathways of airway inflammation in asthma. Barnig C; Frossard N; Levy BD Pharmacol Ther; 2018 Jun; 186():98-113. PubMed ID: 29352860 [TBL] [Abstract][Full Text] [Related]
71. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Serhan CN Anesthesiol Clin; 2006 Jun; 24(2):341-64. PubMed ID: 16927933 [TBL] [Abstract][Full Text] [Related]
72. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration. Serhan CN; Chiang N Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106718. PubMed ID: 36813255 [TBL] [Abstract][Full Text] [Related]
73. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665 [TBL] [Abstract][Full Text] [Related]
74. Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch. Schmid T; Brüne B Front Immunol; 2021; 12():714042. PubMed ID: 34322137 [TBL] [Abstract][Full Text] [Related]
75. Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation. Ferreira I; Falcato F; Bandarra N; Rauter AP Molecules; 2022 Mar; 27(5):. PubMed ID: 35268778 [TBL] [Abstract][Full Text] [Related]
77. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases. Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514 [TBL] [Abstract][Full Text] [Related]
78. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Recchiuti A; Mattoscio D; Isopi E Front Pharmacol; 2019; 10():252. PubMed ID: 31001110 [TBL] [Abstract][Full Text] [Related]
79. The role of specialized pro-resolving mediators in maternal-fetal health. Elliott E; Hanson CK; Anderson-Berry AL; Nordgren TM Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():98-104. PubMed ID: 29031403 [TBL] [Abstract][Full Text] [Related]
80. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling. Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]